Abstract
We describe a 16-year-old neutropenic patient from the Middle East with bloodstream infection caused by two carbapenemase-producing Escherichia coli isolates that we characterized by whole-genome sequencing. While one displayed meropenem resistance and was blaNDM positive, the other demonstrated meropenem susceptibility yet harbored blaOXA181 (which encodes a blaOXA48-like enzyme). This report highlights the challenge of laboratory detection of blaOXA48-like enzymes and the clinical implications of genotypic resistance detection in carbapenemase-producing Enterobacteriaceae.
Original language | English (US) |
---|---|
Pages (from-to) | 3270-3275 |
Number of pages | 6 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 60 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2016 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases